Couillard, S., Shrimanker, R., Chaudhuri, R., Mansur, A., McGarvey, L., Heaney, L., . . . Hinks, T. (2021). FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma. BMJ Publishing Group.
芝加哥风格引文Couillard, S., et al. FeNO Non-suppression Identifies Corticosteroid-resistant Type-2 Signaling in Severe Asthma. BMJ Publishing Group, 2021.
MLA引文Couillard, S., et al. FeNO Non-suppression Identifies Corticosteroid-resistant Type-2 Signaling in Severe Asthma. BMJ Publishing Group, 2021.
警告：这些引文格式不一定是100％准确.